
Мы разошлем вашу новость, анонс или пресс-релиз в более 1000 СМИ

Мы опубликуем вашу новость в самых авторитетных и профильных изданиях России и СНГ

Предоставим подробный отчет, с ссылками на все публикации
Популярные новости
18.07.2018 Бизнес
Adhesion Barrier Market Trends, Share, Growth and Forecast to 2022
The adhesion barrier market size is set to reach $1.3 billion by 2022, growing at a CAGR of 8.5% between 2016-2022. The market is driven by factors such as increase in volume of surgeries, increase in sports related injuries, and growing geriatric population.
Get a Sample Copy of This Report at: https://www.psmarketresearch.com/market-analysis/adhesion-barrier-market/report-sample
The demand for adhesion barrier products is increasing due to increasing sports related injuries. The most common sports related injuries include sprains and strains. According to Stanford Children’s Health in the U.S., every year, more than 3.5 million injuries occur among 30 million children participating in any organized sport and one-third of all injuries that occur during childhood are sports-related injuries. The increasing burden of such sports related injuries is leading to increase in the demand for surgical services including adhesion barrier products, which further enforces government organizations and healthcare providers to provide facilities for effective surgical treatment.
Companies in the adhesion barrier market are entering into partnerships with other firms to improve their market share. For instance, in February 2016, Integra LifeSciences Holding Corporation signed the service alliance agreement with PREZIO Health, to provide services, repair, maintenance and management for surgical instruments under ‘specialty surgical solutions’ business segment.
Explore Report at: https://www.psmarketresearch.com/market-analysis/adhesion-barrier-market
Some of the companies operating in the adhesion barrier market include Medtronic plc, Baxter International Inc., Johnson & Johnson, Sanofi Group, C. R. Bard Inc., MAST Biosurgery AG, Getinge AB, Anika Therapeutics Inc., FzioMed, Inc. and Integra LifeSciences Corporation.